Data / Form D filings / SignalRX Pharmaceuticals, Inc
SignalRX Pharmaceuticals, Inc: Form D filing
SignalRX Pharmaceuticals, Inc, a pharmaceuticals company in Cumming, GA, filed a Form D with the SEC in 2023. The latest, on May 3, 2023, reports $250,000 sold of a $485,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2215 PILGRIM MILL CIRCLE, Cumming, GA, 30041
- Phone
- (770) 815-9331
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1974464
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 3, 2023 | New notice | $485,000 | $250,000 | $235,000 | 2 | Sep 16, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Guillermo Morales | Director | |
| Joel Wernick | Director | |
| Matthew Williams | Executive Officer, Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of May 1, 2023 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SignalRX Pharmaceuticals, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.